EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

Actual possibilities and perspectives of biological drugs in treatment of systemic vasculitides. III. Biological drugs in giant cell arteritis

D. Dimov

Revmatologiia (Bulgaria) · 2021

DOI: 10.35465/29.1.2020.pp8-20 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Revmatologiia (Bulgaria), 2021. Verfasst von D. Dimov. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A review of the literary data about the hitherto exiting investigations on biological drugs (BDs) as an alternative of the corticosteroids (CSs) – the current basal therapy of giant cell arteritis (GCA) is presented. The TNF-alpha-inhibitors are already definitely discarded on the account of their inefficiency and inadequate tolerability. The favorable initial results of BDs against IL-1, CTLA4-iGg1 and especially IL-12/23 should receive a reliable assessment after completion of the additional large-scale investigations. Indisputably only the data on efficacy of tocilizumab (anti-IL-6) for induction and maintenance of GCA remission and its marked CS-saving effect are convincing. Reasonably, TCM received a permission for use as adjunctive therapy in the management of GCA.

Zitieren

APA

Dimov, D. (2021). Actual possibilities and perspectives of biological drugs in treatment of systemic vasculitides. III. Biological drugs in giant cell arteritis. Revmatologiia (Bulgaria). https://doi.org/10.35465/29.1.2020.pp8-20

Vancouver

Dimov D. Actual possibilities and perspectives of biological drugs in treatment of systemic vasculitides. III. Biological drugs in giant cell arteritis. Revmatologiia (Bulgaria). 2021. doi:10.35465/29.1.2020.pp8-20

BibTeX
@article{Dimov2021,
  author = {Dimov, D.},
  title = {Actual possibilities and perspectives of biological drugs in treatment of systemic vasculitides. III. Biological drugs in giant cell arteritis},
  journal = {Revmatologiia (Bulgaria)},
  year = {2021},
  doi = {10.35465/29.1.2020.pp8-20}
}
Kostenlos starten →